FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:511-513 February 18, 1993 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Pereira et al. (Sept. 24 issue)¹ recommended that organs from donors with antibodies to hepatitis C virus (HCV) not be used, even in anti-HCV-positive recipients, because of the heterogeneity of HCV and because the safety of these transplants has not been established^1,2.

In Spain, although the number of renal transplantations is increasing,³ more than 6000 patients who are receiving dialysis are awaiting kidney transplantation. Hence, the policy in our hospitals is to allow the transplantation of anti-HCV-positive kidneys into seropositive recipients if there is good HLA-DR matching and if informed consent has been obtained^4,5.

To . . . [Full Text of this Article]

References

This article has been cited by other articles:

• MORALES, J. M., CAMPISTOL, J. M. (2000). Transplantation in the Patient with Hepatitis C. J. Am. Soc. Nephrol. 11: 1343-1353 [Full Text]